Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection.

Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection.

One of the most relevant risk factors for hepatocellular carcinoma (HCC) development is chronic hepatitis B virus (HBV) infection, but only a fraction of chronic HBV carriers develop HCC, indicating that complex interactions among viral, environmental and genetic factors lead to HCC in HBV-infected...

Full description

Bibliographic Details
Main Authors:	Kelvin Yuen-Kwong Chan, Chun-Ming Wong, Johnny Sheung-Him Kwan, Joyce Man-Fong Lee, Ka Wai Cheung, Man Fung Yuen, Ching Lung Lai, Ronnie Tung-Ping Poon, Pak Chung Sham, Irene Oi-Lin Ng
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22174901/pdf/?tool=EBI

Similar Items

Hepatocellular carcinoma: recent advances and emerging medical therapies [version 1; peer review: 2 approved]
by: Kwan-Lung Ko, et al.
Published: (2020-06-01)

Duodenopleural Fistula Formation After Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma
by: Fion S. Chan, et al.
Published: (2007-10-01)

Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma.
by: Ivan Fan-Ngai Hung, et al.
Published: (2016-01-01)

Evolutionary Changes of Hepatitis B Virus Pre-S Mutations Prior to Development of Hepatocellular Carcinoma.
by: An-Ye Zhang, et al.
Published: (2015-01-01)

Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma
by: Fung-Yu Huang, et al.
Published: (2019-08-01)

Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective
by: Rex Wan-Hin Hui, et al.
Published: (2023-04-01)

First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients
by: Lung-Yi Mak, et al.
Published: (2021-03-01)

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma
by: Daniel Wai-Hung Ho, et al.
Published: (2021-06-01)

Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
by: Ka Shing Cheung, et al.
Published: (2023-01-01)

Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection
by: Lung-Yi Mak, et al.
Published: (2021-06-01)

Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”
by: Lung-Yi Mak, et al.
Published: (2023-01-01)

Characterization and optimized engineering of bosonic quantum interfaces under single-mode operational constraints
by: Pak-Tik Fong, et al.
Published: (2024-02-01)

The role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinoma.
by: Wei Geng, et al.
Published: (2011-01-01)

Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed
by: Ching-Lung Lai, et al.
Published: (2020-06-01)

PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent MannerSummary
by: Charles Shing Kam, et al.
Published: (2023-01-01)

Laparoscopic Liver Resection for Hepatocellular Carcinoma
by: Carmen D. Chung, et al.
Published: (2010-10-01)

Swelling assessment after total knee arthroplasty
by: LI Ka Yau, et al.
Published: (2022-09-01)

Screening strategy for non-alcoholic fatty liver disease
by: Saisai Zhang, et al.
Published: (2023-02-01)

The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance.
by: Ariel Ka-Man Chow, et al.
Published: (2013-01-01)

Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition.
by: Chris K Sun, et al.
Published: (2011-01-01)

Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
by: Zoe Leung, et al.
Published: (2019-10-01)

Small Extracellular Vesicle‐Derived vWF Induces a Positive Feedback Loop between Tumor and Endothelial Cells to Promote Angiogenesis and Metastasis in Hepatocellular Carcinoma
by: Samuel Wan Ki Wong, et al.
Published: (2023-09-01)

Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese.
by: Danny Ka-Ho Wong, et al.
Published: (2013-01-01)

Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.
by: Wing Lung Yau, et al.
Published: (2013-01-01)

A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B.
by: Wai-Kay Seto, et al.
Published: (2011-01-01)

High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B.
by: Wai-Kay Seto, et al.
Published: (2012-01-01)

A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.
by: Wai-Kay Seto, et al.
Published: (2012-01-01)

On the Diversification Effect in Solvency II for Extremely Dependent Risks
by: Yongzhao Chen, et al.
Published: (2023-08-01)

Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma
by: Tan-To Cheung, et al.
Published: (2023-05-01)

Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy
by: Lok-Ka Lam, et al.
Published: (2023-08-01)

Is there difference and correlation between medial and lateral tibial plateau coronal obliquity in native knee? A radiographic study
by: Thomas Ka Chun Leung, et al.
Published: (2021-11-01)

The role of different viral biomarkers on the management of chronic hepatitis B
by: Lung-Yi Mak, et al.
Published: (2023-04-01)

RNA interference as a novel treatment strategy for chronic hepatitis B infection
by: Rex Wan-Hin Hui, et al.
Published: (2022-07-01)

Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma.
by: Jessie Wai-Fong Yuen, et al.
Published: (2014-01-01)

How well do elderly patients do after total knee arthroplasty in the era of fast-track surgery?
by: Amy Cheung, et al.
Published: (2020-06-01)

Modifying Puree Meals in Residential Aged Care Facilities: A Multi-Centre Feasibility and Acceptability Study
by: Dai Pu, et al.
Published: (2021-11-01)

Artificial neural network accurately predicts hepatitis B surface antigen seroclearance.
by: Ming-Hua Zheng, et al.
Published: (2014-01-01)

Lessons learnt from the impact of COVID-19 on arthroplasty services in Hong Kong: how to prepare for the next pandemic?
by: Lok Sze Lee, et al.
Published: (2021-09-01)

Pancreatic-induced Intramural Duodenal Haematoma
by: Julius K. Ma, et al.
Published: (2008-04-01)

Anti-HBc: a significant host predictor of spontaneous HBsAg seroclearance in chronic hepatitis B patients - a retrospective longitudinal study
by: Karin Kan, et al.
Published: (2023-10-01)